ImageneBio, Inc.
IMA· Nasdaq
Released Aug 10, 2023, before the open
10-Q filed Aug 10, 2023, 41 days after period end · 0000950170-23-040943
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $2.00M | $382.00K | $3.55M | $3.07M |
| Net Income | -$17.12M | -$20.49M | -$12.68M | -$5.04M |
| EPS Diluted | -$0.44 |
ImageneBio, Inc. · CIK 1835579 · Engraved from SEC EDGAR
| -$0.57 |
| -$0.35 |
| -$1.89 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.